Episode

Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Podcast: Lung Cancer Update
Published: Aug 8, 2025
Duration seconds: 3542
Processing state: not_requested
Canonical source: https://lung-cancer-update.captivate.fm/episode/5521-yir2024-nontargetedlung
Audio: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/d755cd82-e980-4e79-aca5-1b58ef497e43.mp3
JSON: /v1/public/podcasts/lung-cancer-update-827388/episodes/non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances
Markdown: /podcast/lung-cancer-update-827388/non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances.md

Actions

POST https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/lung-cancer-update-827388/non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies for localized and advanced non-small cell lung cancer without a targetable mutation.  CME information and select publications here .